Philippines Pharmaceuticals and Healthcare Report Q4 2015

Date: September 2, 2015
Pages: 132
Price:
US$ 1,295.00
Publisher: BMI RESEARCH
Report type: Strategic Report
Delivery: Download
ID: P73973A1DC4EN
Leaflet:

Download PDF Leaflet

Philippines Pharmaceuticals and Healthcare Report Q4 2015
Includes 3 FREE quarterly updates

BMI View: The proposed 2016 government budget will be positive for the Philippines healthcare sector. The budget proposes a significant increase in funds allocated to the Department of Health which will enable authorities to finance the expansion of the country's health insurance scheme and upgrade medical facilities in the country. These two thrusts collectively address some of the key impediments to healthcare access in the Philippines and will reinforce commercial opportunities for pharmaceutical companies operating in the country. However, further price caps on high-value medicines and poor intellectual property protection continue to pose a substantial risk for multinational drugmakers.

Headline Expenditure Projections
  • Pharmaceuticals: PHP145.05bn (USD3.28bn) in 2014, rising to PHP150.49bn (USD3.32bn) in 2015; +3.8% in local currency terms and +1.0% in US dollar terms. Forecast revised upwards from last quarter.
  • Healthcare: PHP563.49bn (USD12.75bn) in 2014, rising to PHP623.75bn (USD13.74bn) in 2015; +10.7% in local currency terms and +7.8% in US dollar terms. Revised downwards from last quarter.
BMI Industry View
SWOT
Political
Economic
Operational Risk
Industry Forecast
Pharmaceutical Market Forecast
  Table: Pharmaceutical Sales, Historical Data And Forecasts (Philippines 2011-2019)
Healthcare Market Forecast
  Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2011-2019)
  Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2011-2019)
  Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2011-2019)
Prescription Drug Market Forecast
  Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Philippines 2011-2019)
Patented Drug Market Forecast
  Table: Patented Drug Market Indicators, Historical Data And Forecasts (Philippines 2011-2019)
Generic Drug Market Forecast
  Table: Generic Drug Market Indicators, Historical Data And Forecasts (Philippines 2011-2019)
OTC Drug Market Forecast
  Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Philippines 2011-2019)
Pharmaceutical Trade Forecast
  Table: Pharmaceutical Trade Data And Forecasts (Philippines 2013-2019)
  Table: Pharmaceutical Trade Data And Forecasts local currency (Philippines 2013-2019)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
  Table: Economic Activity (Philippines 2010-2019)
Industry Risk Reward Indices
Asia Pacific Risk/Reward Index
Philippines Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Healthcare Sector
  Table: Healthcare Resources (Philippines 2009-2014)
  Table: Healthcare Personnel (Philippines 2009-2014)
  Table: Healthcare Activity (Philippines 2009-2014)
Health Insurance
Healthcare Sector Financing
Medical Tourism
Biotechnology And Research
Traditional Medicines
Clinical Trials
Regulatory Development
  Table: History Of Food And Drugs Administration
Intellectual Property Regime
Pricing Regime
  Table: Medicines Subject To March 31 2010 Government Mediated Access Price
Reimbursement Regime
International Cooperation
Competitive Landscape
Pharmaceutical Industry
  Table: Pharmaceutical Industry Overview
Domestic Pharmaceutical Industry
Pharmaceutical Distribution And Retail
  Table: Overview Of BnB, BNB and P100 Programme
  Table: Cost Of Generic Drugs In Philippines (PHP)
  Table: Number Of BnBs And BNBs In Selected Philippine Regions
Company Profile
GlaxoSmithKline Philippines
MediChem Pharmaceuticals
Merck & Co
Novartis
Pacific Pharmaceutical Generics
Pascual Laboratories
Pfizer
Sanofi
Unilab
Demographic Forecast
  Table: Population Headline Indicators (Philippines 1990-2025)
  Table: Key Population Ratios (Philippines 1990-2025)
  Table: Urban/Rural Population & Life Expectancy (Philippines 1990-2025)
  Table: Population By Age Group (Philippines 1990-2025)
  Table: Population By Age Group % (Philippines 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
  Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings
Skip to top


Ask Your Question

Philippines Pharmaceuticals and Healthcare Report Q4 2015
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: